Changes in intestinal absorption of 5-fluorouracil treated rats

Pharmacology and Toxicology

Volumn 85, Issue 3, 1999, Pages 33-36

  Hirata, Kohji ^a   Horie, Toshiharu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; INTESTINE; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0033044059     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb01060.x     Document Type: Article

References (24)

1. Capel, I. D., M. H. Pinnock & D. C. Williams: All in vitro assessment of the effect of cytotoxic drugs upon the intestinal absorption of nutrients in rats. Eur. J. Cancer 1979, 15, 127-131.
2. Diasio, R. B. & B. E. Harris: Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokin. 1989, 16, 215-237.
3. Doluisio, J. T., N. F. Billups, L. W. Dittert, E. T. Sugita & J. V. Swintosky: Drug absorption I: An in situ rat gut technique yielding realistic absorption rates. J. Pharm. Sci. 1969, 58, 1196-1200.
4. Gotoh, S., R. Nakamura, M. Nishiyama, Y. S. Quan, T. Fujita, A. Yamamoto & S. Muranishi: Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine. J. Pharm. Sci. 1996, 85, 858-862.
5. Hehvar, R., M. A. Robinson & J. M. Reynolds: Molecular weight dependent tissue accumulation of dextrans: In vitro studies in rats. J. Phurm. Sci. 1994, 83, 1495-1499.
6. Horie, T., M. Nakamaru & Y. Masubuchi: Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. Life Sci. 1998, 62, 1333-1338.
7. Houghton, J. A., P. J. Houghton & R. S. Wooten: Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2′-deoxyuridine. Cancer Res. 1979, 39, 2406-2413.
8. Jenkins, R. T., R. L. Goodacre, P. J. Rooney, J. Bienenstock, T. Sivakumaran & W. H. Christopher Walker: Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin. Biochem. 1986, 19, 298-302.
9. 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Amer. J. Gastroenterology 1987, 82, 1159-1164.
10. Kosakai, Y., T. Horie & S. Awazu: Protective effect of vitamin A against the methotrexate-induced damage to small intestine: A study on the crypt cells. Pharmacology & Toxicology 1991, 69, 291-295.
11. Kralovanszky, J., N. Prajda, S. Kerpel-Fronius, T. Bagrij, E. Kiss & G. J. Peters: Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine. Cancer Chemother. Pharmacol. 1993, 32, 243-248.
12. Malin, M., E. Isolauri, P. Pikkarainen, R. Karikoski & J. Isolauri: Enhanced absorption of macromolecules: A secondary factor in Crohn's disease. Dig. Dis. Sci. 1996, 41, 1423-1428.
13. Milles, S. S., A. L. Muggia & H. M. Spiro: Colonic histologic changes induced by 5-fluorouracil. Gastroenterology 1962, 43, 391-399.
14. Mizuno, M., M. Tamura, M. Hashida & H. Sezaki: Effects of mitomycin C, 5-fluorouracil and cyclophosphamide on drug absorption, enzyme activities and mucosal lipid composition of intestine. J. Pharmacobio-Dyn. 1987, 10, 321-329.
15. Nakamaru, M., Y. Masubuchi, S. Narimatsu, S. Awazu & T. Horie: Evaluation of damaged small intestine of mouse following methotrexate administration. Cancer Chemother. Pharmacol. 1998, 41, 98-102.
16. Nagai, Y., T. Horie & S. Awazu: Vitamin A, a useful biochemical modulator capable of preventing intestinal damage during methotrexate treatment. Pharmacology & Toxicology 1993, 73, 69-74.
17. Ohkuni, A.: Effects of 5-fluorouracil on glucose absorption in the hamster jejunum. Teikyo Igaku Zasshi 1984, 7, 345-355.
18. Roche, A. C., J. C. I. Bognel, C. Bognel & J. J. Bernier: Correlation between the histological changes and glucose intestinal absorption following a single dose of 5-fluorouracil. Digestion 1970, 3, 195-212.
19. Siber, G. R., R. J. Mayer & M. J. Levin: Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res. 1980, 40, 3430-3436.
20. Smith, P., C. Mirabelli, J. Fondacaro, F. Ryan & J. Dent: Intestinal 5-fluorouracil absorption: Use of ussing chambers to assess transport and metabolism. Pharm. Res. 1988, 5, 598-603.
21. Tsurui, K., Y. Kosakai, T. Horie & S. Awazu: Vitamin A protects the small intestine from methotrexate-induced damage in rats. J. Pharmacol. Exp. Therap. 1990, 253, 1278-1284.
22. Wu, A. T., J. L. Au & W. Sadēe: Hydroxylated metabolites of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur} in rats and rabbits. Cancer Res. 1978, 38, 210-214.
23. Yamamoto, J., T. Horie & S. Awazu: Amelioration of methotrexate-induced malabsorption by vitamin A. Cancer Chemother. Pharmacol. 1997, 39, 239-244.
24. Yuasa, H., K. Matsuda, J. Gu, E. Suzuki, I. Yokouchi & J. Watanabe: Dose-dependent gastrointestinal absorption of 5-fluorouracil in rats in vivo. Biol. Pharm. Bull. 1996, 19, 1494-1498.